Bank of America Corp. (NYSE:BAC): Current price $14.74
Through its Community Development Banking division, Bank of America Merrill Lynch supplied more than $1.6 billion in loans, tax credit equity investments, and other real estate development solutions in the first half of the year. Those commitments were twice the amount of lending and investing for the same period in 2012, and will help create in excess of 6,500 affordable housing units, the company said.
Micron Technology Inc. (NASDAQ:MU): Current price $13.02
Trustees for Micron and Elpida Memory Inc. announced Wednesday the close of Micron’s purchase of the entirety of Elpida’s equity through a sponsor agreement entered into on July 2, 2012 and linked with Elpida’s corporate reorganization proceedings conducted under the jurisdiction of the Tokyo District Court. In a connected transaction, Micron also reported the finalization of its acquisition of a 24 percent share of Rexchip Electronics Corp. from Powerchip Technology Corp. and some of its affiliates. For accounting purposes, the transactions will be recorded as being effective at 11:59 p.m. Tokyo time on Wednesday.
Inovio Pharmaceuticals Inc. (NYSE:INO): Current price $2.09
Inovio said on Wednesday that in a preclinical evaluation with two animal models, Inovio’s hTERT (human telomerase reverse transcriptase) DNA cancer vaccine administered with Inovio’s Cellectra adaptive electroporation delivery technology generated robust and broad immune responses, broke the immune system’s tolerance to its self-antigens, induced T-cells with a tumor-killing function, and raised the rate of survival. High levels of hTERT expression are found in 85 percent of human cancers, regardless of type, and Inovio’s cancer candidate has the potential to perform as a “universal” cancer therapeutic based on these early results, the company said.